You are here

Keranetics, LLC

Company Information
Address
200 1St Street West
Winston Salem, NC 27101-4051
United States


http://www.keranetics.com

Information

DUNS: 827054219

# of Employees: 19


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. KeraStat(R) Burn Gel and Halofuginone to Prevent Scar Contracture after Burn Injuries

    Amount: $699,140.00

    No currently available burn product has shown efficacy in substantially decreasing wound healing time and preventing scar formation. The goals of this Phase II proposal are to expand on the results ob ...

    SBIRPhase II2020Department of Defense Defense Health Agency
  2. Development of Technologies that Address the Complex Architecture of the Face During the Treatment of Severe Facial Burn Injury

    Amount: $948,754.00

    Burn injuries to theface present a number of functional and psychological challenges that arisefrom scarring and contracture. Thus, amajor goal of burn and trauma surgeons is to prevent scarring and i ...

    SBIRPhase II2017Department of Defense Defense Health Agency
  3. Development of Biocompatible Dressings for the Delivery of Analgesics to Burn Wounds

    Amount: $998,790.44

    This Phase II project is relevant to the medical product research goals of the Department of Defense given the prevalence of complex burn wounds that cause both acute and chronic pain. The current sol ...

    SBIRPhase II2016Department of Defense Army
  4. Spatiotemporally Controlled Keratin Biomaterial Delivery System for Functional Tissue Regeneration

    Amount: $999,999.00

    Currently, no commercial products exist for the repair of large injuries to muscle, particularly volumetric muscle loss (VML). In Phase I of this project, data demonstrated that keratin biomaterials c ...

    SBIRPhase II2015Department of Defense Defense Health Agency
  5. Development of Technologies that Address the Complex Architecture of the Face During the Treatment of Severe Facial Burn Injury

    Amount: $999,656.00

    Burn injuries, particularly those to the face, present a number of functional and psychological challenges that arise from scarring and related contracture. A major goal of trauma and burn surgeons i ...

    SBIRPhase II2015Department of Defense Defense Health Agency
  6. Development of Technologies that Address the Complex Architecture of the Face During the Treatment of Severe Facial Burn Injury

    Amount: $149,986.00

    With the advent of improved body armor and vehicles and the enemy"s use of the improved explosion device (IED) in the most recent conflicts, blast injuries and related burns to the face have become mo ...

    SBIRPhase I2014Department of Defense Defense Health Agency
  7. Development of Biocompatible Dressings for the Delivery of Analgesics to Burn Wounds

    Amount: $99,935.00

    This Phase I project is relevant to the goals of this program announcement given the prevalence of complex burn wounds that cause both acute and chronic pain. The current solution to burn-related pai ...

    SBIRPhase I2014Department of Defense Army
  8. KeraStat(TM) Burn Gel and Halofuginone to Prevent Scar Contracture after Burn Injuries

    Amount: $149,834.00

    This Phase I project is relevant to the ultimate goals of this program announcement given the prevalence of the IED which often creates complex burn wounds on the face and skin that often form hypertr ...

    SBIRPhase I2013Department of Defense Defense Health Agency
  9. Flowable keratin biomaterials for improving infection control and wound healing, Phase 2.

    Amount: $751,604.00

    Improvements in body armor, availability of equipment, and decreased patient transport times have dramatically improved Soldiers survival of combat injuries. Data suggests that future conflicts will ...

    SBIRPhase II2013Department of Defense Army
  10. Keratin biomaterial-based fluid for trauma resuscitation

    Amount: $778,026.00

    DESCRIPTION (provided by applicant): Although numerous advances have been made in the treatment of severe hemorrhage, current blood plasma substitutes do not address new insights in resuscitation medi ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government